Treatment of hepatitis C with thymosin and peptide combination therapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 24, 2007
Grant Date -
Oct 2, 2003
app pub date -
Feb 7, 2003
filing date -
Aug 7, 2000
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method and pharmaceutical combination for treating hepatitis C by administering to a hepatitis C patient an effective amount of at least one alpha thymosin peptide, in combination with administration to the hepatitis C patient of an effective amount of at least one interferon, and optionally in combination with administration of at least one antiviral agent such as ribavirin.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully